Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
FEBS Lett. 2011 Jul 7;585(13):2087-99. doi: 10.1016/j.febslet.2010.08.009. Epub 2010 Aug 11.
MicroRNAs have emerged as key post-transcriptional regulators of gene expression, involved in various physiological and pathological processes. It was found that several miRNAs are directly involved in human cancers, including lung, breast, brain, liver, colon cancer and leukemia. In addition, some miRNAs may function as oncogenes or tumor suppressors in tumor development. Furthermore, a widespread down-regulation of miRNAs is commonly observed in human cancers and promotes cellular transformation and tumorigenesis. More than 50% of miRNA genes are located in cancer-associated genomic regions or in fragile sites, frequently amplified or deleted in human cancer, suggesting an important role in malignant transformation. A better understanding of the miRNA regulation and misexpression in cancer may ultimately yield further insight into the molecular mechanisms of tumorigenesis and new therapeutic strategies may arise against cancer. Here, we discuss the occurrence of the deregulated expression of miRNAs in human cancers and their importance in the tumorigenic process.
MicroRNAs 已成为基因表达的关键转录后调控因子,参与各种生理和病理过程。研究发现,几种 miRNAs 直接参与人类癌症,包括肺癌、乳腺癌、脑癌、肝癌、结肠癌和白血病。此外,一些 miRNAs 在肿瘤发展过程中可能作为癌基因或肿瘤抑制因子发挥作用。此外,在人类癌症中通常观察到 miRNAs 的广泛下调,促进细胞转化和肿瘤发生。超过 50%的 miRNA 基因位于癌症相关基因组区域或脆性位点,在人类癌症中经常扩增或缺失,表明其在恶性转化中具有重要作用。更好地理解 miRNA 在癌症中的调控和异常表达,可能最终深入了解肿瘤发生的分子机制,并产生针对癌症的新治疗策略。在这里,我们讨论了 miRNAs 在人类癌症中的失调表达的发生及其在肿瘤发生过程中的重要性。
FEBS Lett. 2010-8-11
Dev Biol. 2007-2-1
Trends Mol Med. 2010-5-20
Epigenetics. 2017-3-4
Cancer Lett. 2009-11-28
Adv Exp Med Biol. 2019
Adv Cancer Res. 2016-8-9
Adv Exp Med Biol. 2016
J Exp Clin Cancer Res. 2025-4-21
Front Cell Dev Biol. 2024-8-28
Asian Pac J Cancer Prev. 2024-6-1
Mol Biol Rep. 2024-1-28